Evaluation of a two-test serodiagnostic method for community assessment of Lyme disease in an endemic area

American Journal of Tropical Medicine and Hygiene

Volumn 65, Issue 5, 2001, Pages 563-566

  Trevejo, R T ^a   Krause, P J ^a   Schriefer, M E ^a   Dennis, D T ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYME DISEASE VACCINE;

ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; SERODIAGNOSIS; UNITED STATES; VACCINATION; WESTERN BLOTTING;

EID: 0035208097     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2001.65.563     Document Type: Article

References (16)

1. Lyme disease - United States, 1996
2. Reported distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the United States
3. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease
4. Epidemiologic and diagnostic studies of patients with suspected early Lyme disease, Missouri 1990-1993
5. Serodiagnosis of Lyme disease: Accuracy of a two-step approach using a flagella-based ELISA and immunoblotting
6. Low seroprevalence of human Lyme disease near a focus of high entomologic risk
7. Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States
8. Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice
9. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant outer-surface protein A lyme disease vaccine study consortium
10. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme disease vaccine study group
11. Lyme disease - United States, 1995
12. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens
13. A limitation of 2-stage serological testing for Lyme disease: Enzyme immunoassay and immunoblot assay are not independent tests
14. Disparity between serological reactivity to Borrelia burgdorferi and evidence of past disease in a high-risk group
15. Effects of OspA vaccination on Lyme disease serologic testing